{"gene":"ALDH3A1","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2003,"finding":"Human ALDH3A1 expressed in Sf9 insect cells and purified demonstrates high substrate specificity for medium-chain (≥6 carbon) saturated and unsaturated aldehydes including 4-hydroxy-2-nonenal (4-HNE), while short-chain aldehydes (acetaldehyde, propionaldehyde, malondialdehyde) are very poor substrates; glyceraldehyde is metabolized poorly and glucose-6-phosphate, 6-phosphoglucono-delta-lactone, and 6-phosphogluconate are not metabolized at all.","method":"Recombinant protein expression in Sf9 cells, affinity chromatography purification, in vitro enzymatic assays with defined substrates","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted recombinant enzyme with comprehensive substrate panel, multiple orthogonal methods","pmids":["12943535"],"is_preprint":false},{"year":2001,"finding":"Stable transfection of human ALDH3A1 in V79 cells confers protection against growth inhibition and apoptosis induced by medium-chain aldehydes (hexanal, trans-2-hexenal, trans-2-octenal, trans-2-nonenal, 4-HNE) by oxidizing them to their corresponding carboxylic acids, preventing glutathione depletion and protein adduct formation; ALDH3A1 completely blocked HNE-induced apoptosis in both V79 and RAW 264.7 macrophage cells.","method":"Stable transfection, cell viability assays, glutathione measurement, protein adduct detection, apoptosis assays, in vitro enzymatic assays with crude cytosol","journal":"Chemico-biological interactions","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods, two cell line systems, mechanistic follow-up with substrate specificity","pmids":["11306050"],"is_preprint":false},{"year":2003,"finding":"Stable transfection of ALDH3A1 in human corneal epithelial cells (HCE) protects against UV- and 4-HNE-induced cytotoxicity and apoptosis (via caspase-3/PARP pathway); ALDH3A1-expressing cells had 50% higher NAD(P)H levels upon 4-HNE treatment and prevented 4-HNE–protein adduct formation, with a Km for 4-HNE of 54 µM.","method":"Stable transfection, UV and 4-HNE cytotoxicity assays, DNA fragmentation assays, caspase-3/PARP Western blot, NAD(P)H measurement, 4-HNE protein adduct detection","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal functional methods in relevant corneal cell line with mechanistic pathway placement","pmids":["12706498"],"is_preprint":false},{"year":2006,"finding":"ALDH3A1 stably transfected in rabbit corneal fibroblastic cells (TRK43) protects against H2O2-, mitomycin C-, and etoposide-induced apoptosis and oxidative damage by metabolizing 4-HNE, maintaining glutathione homeostasis, and sustaining redox balance; increased carbonylation of ALDH3A1 occurs after treatment without significant loss of enzymatic activity.","method":"Stable transfection, oxidative stress assays, apoptosis detection, GSH measurement, 4-HNE adduct Western blot","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in corneal cell line, multiple stressors tested","pmids":["17023273"],"is_preprint":false},{"year":2006,"finding":"ALDH3A1 protects glucose-6-phosphate dehydrogenase (G6PDH) from inactivation by 4-HNE and malondialdehyde when co-incubated with NADP+, demonstrating enzymatic protection of other proteins; at large excess, ALDH3A1 directly absorbs UVB and shields G6PDH from UV inactivation. ALDH3A1 also undergoes a structural transition near physiological temperatures to a partially unfolded conformation suggestive of chaperone activity.","method":"In vitro co-incubation assays with recombinant proteins, G6PDH activity measurements, UV exposure experiments, spectroscopic analysis of structural transitions","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with mechanistic controls, multiple protective mechanisms demonstrated","pmids":["17158879"],"is_preprint":false},{"year":2007,"finding":"Aldh3a1−/− and Aldh1a1−/−/Aldh3a1−/− double knockout mice develop cataracts (anterior and posterior subcapsular and punctate cortical opacities) by 1 month of age; UVB exposure accelerates anterior lens opacification more in Aldh3a1−/− mice; cataract formation is associated with decreased proteasomal activity, increased protein oxidation, and increased 4-HNE and malondialdehyde-protein adducts, demonstrating that ALDH3A1 protects against cataract through both enzymatic and non-enzymatic (light-filtering) functions.","method":"Single and double knockout mouse models, UVB exposure, slit-lamp/histological evaluation, proteasome activity assay, protein carbonylation assay, 4-HNE/MDA adduct Western blots, GSH measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — rigorous in vivo genetic loss-of-function with multiple biochemical readouts, two single and one double KO line","pmids":["17567582"],"is_preprint":false},{"year":2012,"finding":"ALDH3A1 overexpression in TRK43 corneal keratocyte cells protects from 4-HNE-induced cytotoxicity by metabolizing 4-HNE and its glutathione conjugate, preventing 4-HNE–protein adduct formation, blocking apoptosis, maintaining glutathione homeostasis, and preserving proteasome function.","method":"Stable transfection, cell viability assays, morphological evaluation, Western blot for 4-HNE adducts, glutathione assay, proteasome activity assay, apoptosis assays","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal mechanistic readouts in corneal cell line","pmids":["22406320"],"is_preprint":false},{"year":2014,"finding":"Crystallographic and kinetic studies of ALDH3A1 with selective inhibitor CB7 (1-[(4-fluorophenyl)sulfonyl]-2-methyl-1H-benzimidazole, IC50 0.2 µM) show that CB7 binds within the aldehyde-binding pocket of ALDH3A1; mutagenesis confirmed this binding site; CB7 does not inhibit ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, or ALDH2. ALDH3A1-expressing lung adenocarcinoma (A549) and glioblastoma (SF767) cells are sensitized to mafosfamide by CB7, whereas fibroblasts lacking ALDH3A1 are not.","method":"X-ray crystallography, kinetic inhibition assays, active-site mutagenesis, isoenzyme selectivity panel, cell proliferation assays with mafosfamide","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis and kinetics, orthogonal cellular validation","pmids":["24387105"],"is_preprint":false},{"year":2014,"finding":"Crystal structure of ALDH3A1 with inhibitor CB29 shows it binds within the aldehyde substrate-binding site; CB29 does not inhibit ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, or ALDH2 at up to 250 µM, confirming isoenzyme selectivity; sensitizes ALDH3A1-expressing tumor cells (A549, SF767) but not ALDH3A1-negative fibroblasts to mafosfamide.","method":"X-ray crystallography, kinetic characterization, isoenzyme selectivity assays, cell proliferation assays","journal":"Chembiochem : a European journal of chemical biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus kinetics plus cellular functional readout","pmids":["24677340"],"is_preprint":false},{"year":2015,"finding":"Small molecule Alda-89 enables ALDH3A1 to metabolize acetaldehyde (a substrate it normally does not accept); when administered with ALDH2 activator Alda-1, Alda-89 reduced blood ethanol and acetaldehyde levels in vivo in wild-type and ALDH2*1/*2 knock-in mice, demonstrating pharmacological recruitment of ALDH3A1 to expand its substrate specificity.","method":"In vitro enzymatic assay, in vivo mouse model (wild-type and ALDH2*1/*2 knock-in), blood alcohol/aldehyde measurement, behavioral assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzymatic demonstration plus in vivo validation in two mouse genotypes","pmids":["25713355"],"is_preprint":false},{"year":2016,"finding":"Using tetracycline-inducible wild-type and catalytically-inactive ALDH3A1 human corneal epithelial cells (hTCEpi), ALDH3A1 was shown to decrease corneal cell proliferation through both enzymatic and non-enzymatic mechanisms; wild-type but not catalytically-inactive ALDH3A1 promotes p53 nuclear sequestration. In Aldh1a1−/−/Aldh3a1−/− DKO mice, hyperproliferative corneal epithelium shows nearly complete loss of p53 expression.","method":"Tet-inducible cell lines expressing wt or catalytically-inactive ALDH3A1, proliferation assays, p53 nuclear fractionation, DKO mouse corneal analysis, differentiation marker mRNA analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — catalytic mutant dissects enzymatic vs. non-enzymatic mechanism, in vitro and in vivo confirmation","pmids":["26751691"],"is_preprint":false},{"year":2017,"finding":"Recombinant human ALDH3A1 exhibits molecular chaperone-like activity in vitro: it protects SmaI and citrate synthase from thermal stress-induced precipitation and inactivation; overexpression of ALDH3A1 confers E. coli with enhanced resistance to thermal shock and protects HCE-2 corneal cells from H2O2 and tert-butyl hydroperoxide cytotoxicity.","method":"In vitro chaperone assays with recombinant protein and citrate synthase, E. coli thermal shock assays, cell viability assays in corneal cell line","journal":"The international journal of biochemistry & cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution with multiple client proteins plus cellular confirmation","pmids":["28526614"],"is_preprint":false},{"year":2010,"finding":"UV-light causes soluble, non-native aggregation of ALDH3A1 via covalent and non-covalent interactions, leading to loss of enzymatic activity; MALDI-TOF LysC peptide mapping shows UV-induced modifications to Trp, Met, and Cys residues, but the conserved catalytic Cys remains intact after UV exposure, indicating that inactivation results from structural changes rather than direct active-site damage.","method":"UV irradiation of recombinant ALDH3A1, spectroscopic analysis, MALDI-TOF mass spectrometry with LysC peptide mapping, aggregation assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro system with mass spectrometric residue-level characterization","pmids":["21203538"],"is_preprint":false},{"year":2018,"finding":"Chemoproteomics (activity-based protein profiling) identified the catalytic cysteine of ALDH3A1 as the primary target of the covalent ligand DKM 3-42 in non-small cell lung carcinoma cells; a more selective covalent inhibitor, EN40, inhibits ALDH3A1 activity at this catalytic cysteine and impairs lung cancer cell proliferation in vitro and tumor growth in vivo.","method":"Activity-based protein profiling (ABPP), covalent ligand library screen, in vitro cell proliferation assays, in vivo xenograft model","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1-2 — chemoproteomic target identification at residue level, in vitro and in vivo functional validation","pmids":["30004670"],"is_preprint":false},{"year":2015,"finding":"FBXL12 (F-box and leucine-rich repeat protein 12) interacts specifically with ALDH3-family members including ALDH3A1 and mediates their polyubiquitylation, leading to proteasomal degradation; FBXL12-deficient mice accumulate ALDH3 in the placenta and exhibit impaired trophoblast stem cell differentiation, and forced ALDH3A1 expression in wild-type TSCs phenocopies the differentiation defect.","method":"Co-immunoprecipitation, ubiquitylation assay, FBXL12 knockout mice, TSC differentiation assays, forced overexpression rescue experiments, ALDH inhibitor rescue","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction identified, ubiquitylation demonstrated, KO mouse phenotype, gain-of-function phenocopy, inhibitor rescue","pmids":["26124079"],"is_preprint":false},{"year":1999,"finding":"Deletion analysis and transient transfection of 5'-flanking region reporter constructs in mouse hepatoma Hepa-1c1c7 cells show that the Aldh3a1 promoter contains at least four functional aromatic hydrocarbon response elements (AHREs) that act cooperatively for dioxin (TCDD)-mediated induction, a negative regulatory element (NRE) controlling basal expression, and that TCDD-mediated upregulation depends exclusively on the aromatic hydrocarbon receptor (AhR).","method":"Promoter deletion/reporter gene (CAT/luciferase) constructs, transient transfection, AhR dependency assay in Hepa-1c1c7 cells","journal":"Pharmacogenetics","confidence":"High","confidence_rationale":"Tier 2 — systematic deletion analysis identifying functional regulatory elements, AhR dependency established","pmids":["10591537"],"is_preprint":false},{"year":2018,"finding":"Pharmacological Wnt pathway inhibition (LGK974) significantly downregulates ALDH3A1 expression in glioblastoma cells; shRNA-mediated ALDH3A1 knockdown increases TMZ efficacy and reduces clonogenic potential with decreased stem cell markers (CD133, Nestin, Sox2), placing ALDH3A1 downstream of Wnt/β-catenin signaling in glioblastoma chemoresistance.","method":"shRNA knockdown, pharmacological Wnt inhibition, transcriptomic analysis, clonogenic assay, proliferation assay, stem cell marker expression","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods but single lab, pathway placement via pharmacological and genetic approaches","pmids":["29854309"],"is_preprint":false},{"year":2018,"finding":"In Per2-mutant oncogene-transformed fibroblasts, ALDH3A1 protein is ~7-fold higher than in wild-type transformed cells, correlating with chemoresistance; shRNA knockdown of Aldh3a1 in Per2-mutant cells relieves resistance to methotrexate, gemcitabine, etoposide, vincristine, and oxaliplatin by restoring chemotherapy-induced reactive oxygen species accumulation, placing ALDH3A1 downstream of the PER2 circadian clock component in drug resistance.","method":"Per2-mutant mouse embryonic fibroblasts, shRNA knockdown, chemotherapy cytotoxicity assays, ROS measurement, Western blot for ALDH3A1","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis via shRNA rescue, ROS mechanism defined, single lab","pmids":["30429219"],"is_preprint":false},{"year":2006,"finding":"Arachidonic acid treatment of A549 lung tumor cells reduces ALDH3A1 enzymatic activity, protein, and mRNA levels, associated with increased PPARγ expression and decreased NF-κB binding; selective PPARγ antagonist GW9662 prevents both ALDH3A1 reduction and A549 cell growth inhibition, identifying PPARγ activation as upstream repressor of ALDH3A1 expression.","method":"PPARγ antagonist treatment, ALDH3A1 mRNA/protein/activity measurement, NF-κB binding assay, cell growth assay, vitamin E co-treatment","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological epistasis linking PPARγ to ALDH3A1, multiple molecular readouts, single lab","pmids":["16716894"],"is_preprint":false},{"year":2017,"finding":"NRF2 knockdown in pancreatic cancer cells markedly reduces ALDH3A1 expression, placing ALDH3A1 transcriptionally downstream of NRF2-mediated antioxidant signaling.","method":"siRNA knockdown of NRF2, RT-PCR/Western blot for ALDH3A1 expression, GCLC co-regulation analysis","journal":"Antioxidants (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 3 — single method (siRNA + expression), single lab, limited mechanistic follow-up","pmids":["28671577"],"is_preprint":false},{"year":2020,"finding":"aldh3a1−/− zebrafish generated by CRISPR-Cas9 display retinal vasodilatory alterations and impaired glucose homeostasis; 4-HNE (but not methylglyoxal) was elevated in aldh3a1 mutants, establishing 4-HNE as the primary substrate of Aldh3a1 in vivo and linking impaired 4-HNE detoxification to pancreatic disruption and hyperglycemia.","method":"CRISPR-Cas9 knockout zebrafish, transgenic reporter lines for vasculature/pancreas, reactive carbonyl species measurement, transcriptome, metabolomics, ALDH activity assay, pdx1 silencing epistasis","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 — CRISPR knockout with multi-omics and pharmacological rescue, in vivo substrate identification","pmids":["32980661"],"is_preprint":false},{"year":2018,"finding":"ALDH3A1 knockdown in sulfasalazine-resistant HNSCC cells sensitizes them to the xCT inhibitor sulfasalazine; dyclonine (a covalent ALDH inhibitor) combined with sulfasalazine induces intracellular 4-HNE accumulation synergistically, demonstrating that ALDH3A1-mediated 4-HNE detoxification is the mechanism of resistance to glutathione depletion-induced cell death.","method":"shRNA knockdown, drug combination assays, 4-HNE intracellular measurement, tumor growth assay in vivo","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological convergence on 4-HNE mechanism, in vivo confirmation, single lab","pmids":["30333913"],"is_preprint":false},{"year":2025,"finding":"TP63 transcription factor binds to the super-enhancer of ALDH3A1 to drive its high expression in squamous cell carcinomas; ALDH3A1 enzymatic activity (not just protein presence) protects SCC cells against ferroptosis by catalyzing aldehyde oxidation and mitigating lipid peroxidation; the covalent inhibitor EN40 enhances ferroptosis sensitivity.","method":"ChIP-seq for TP63 super-enhancer binding, covalent inhibitor EN40, cell viability assays, organoid models, in vivo xenograft, lipid peroxidation measurement","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — multiple in vitro and in vivo methods, transcriptional regulation identified, enzymatic dependency shown via specific inhibitor","pmids":["39863749"],"is_preprint":false},{"year":2003,"finding":"UV radiation decreases corneal ALDH3A1 mRNA, protein, and enzymatic activity in C57BL/6J mice; at lower UVB doses, enzymatic activity decreases without transcriptional changes, indicating post-translational modification; in vitro studies with purified recombinant ALDH3A1 and stably transfected HCE cells show UV causes covalent and non-covalent protein aggregation.","method":"Northern blot, Western blot, enzymatic activity assay, in vitro UV irradiation of recombinant protein and transfected cell lines","journal":"Chemico-biological interactions","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro convergent data identifying post-translational regulation, multiple methods","pmids":["12604188"],"is_preprint":false},{"year":2025,"finding":"ALDH3A1 loss in FANCA-deficient keratinocytes causes synthetic lethality with DNA damage marker induction; loss of four functionally redundant ALDH3 isozymes causes lipid aldehyde accumulation; FA-deficient keratinocytes are more sensitive to 4-HNE than FA-competent cells, establishing ALDH3-family enzymes (including ALDH3A1) as a tier-1 defense against lipid aldehyde-induced DNA damage in keratinocytes.","method":"Systematic CRISPR/shRNA inactivation of ALDH/ADH genes in FANCA-deficient keratinocyte lines, DNA damage marker assays, 4-HNE sensitivity assays, NAC rescue","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — systematic genetic screen with mechanistic follow-up, but preprint; ALDH3A1 among redundant family members","pmids":["bio_10.1101_2025.11.13.688345"],"is_preprint":true},{"year":2025,"finding":"A conserved RH/QxxR sequence motif in ALDH3A1 (and other ALDH3 family members) enables activity with non-canonical redox cofactor NMN+ (nicotinamide mononucleotide); Bos taurus ALDH3A1 shows unprecedented turnover with NMN+, with kcat values matching or exceeding NAD+; structural analysis shows the motif reinforces cofactor positioning and pre-organizes the active site without requiring the adenosine monophosphate moiety of NAD+.","method":"Enzymatic kinetics, X-ray crystallography, molecular dynamics, mutagenesis of the RH/QxxR motif in diverse ALDH scaffolds","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 — structural and kinetic data with mutagenesis, but preprint","pmids":["bio_10.1101_2025.08.01.668186"],"is_preprint":true},{"year":2026,"finding":"Dietary isothiocyanates (specifically allyl-isothiocyanate) form a covalent adduct with the ALDH3A1 catalytic cysteine residue (Cys243), causing irreversible inhibition of salivary ALDH3A1 activity both in vitro and ex vivo; this inhibition disrupts metabolic conversion of odorant aldehydes in saliva.","method":"X-ray crystallography, mass spectrometry adduct identification, in vitro enzymatic assay, ex vivo saliva assays, GC-MS aroma analysis","journal":"Food chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure identifying covalent adduct on catalytic Cys243, confirmed by MS and enzymatic assays","pmids":["41672019"],"is_preprint":false},{"year":1999,"finding":"Four amino acid substitutions (G88R, I154N, H305R, I352V) in the Aldh3a1c allele of SWR/J mice are responsible for near-complete loss of ALDH3A1 enzymatic activity in all tissues; I154N disrupts a potential alpha helix in the Rossmann fold and H305R affects a beta strand potentially impacting catalytic activity; mRNA levels are unchanged between 'low-activity' and 'high-activity' variants, indicating post-translational/structural basis for activity differences.","method":"RT-PCR amplification and sequencing of ALDH3A1 cDNA from multiple inbred mouse strains, enzymatic activity assays across tissues, sequence analysis","journal":"Pharmacogenetics","confidence":"Medium","confidence_rationale":"Tier 2 — natural variant analysis with enzymatic confirmation identifying structure-function relationships","pmids":["10376761"],"is_preprint":false},{"year":2023,"finding":"ALDH3A1 promotes glycolysis and suppresses oxidative phosphorylation (OXPHOS) in NSCLC cells by activating the HIF-1α/LDHA pathway; its expression is induced by hypoxia; β-elemene downregulates ALDH3A1 to inhibit glycolysis and enhance OXPHOS, suppressing NSCLC proliferation in vitro and in vivo.","method":"ALDH3A1 knockdown/overexpression, metabolic flux analysis (glycolysis/OXPHOS), HIF-1α/LDHA pathway analysis, β-elemene treatment, in vivo xenograft","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway placement via gain/loss of function with metabolic readouts, in vivo confirmation, single lab","pmids":["37730658"],"is_preprint":false},{"year":2024,"finding":"Mechanical strain (3%) applied to human keratocytes upregulates ALDH3A1 expression; increased ALDH3A1 inhibits NF-κB nuclear translocation, suppressing keratocyte proliferation and migration; ALDH3A1 knockdown promotes NF-κB nuclear translocation and enhances proliferation and migration, establishing ALDH3A1 as a mechanosensitive regulator of NF-κB signaling in corneal stroma.","method":"Flexcell tension system, RT-qPCR, Western blot, RNAi knockdown, NF-κB nuclear translocation immunofluorescence, BrdU proliferation assay, scratch wound healing assay, mouse injury models, single-cell RNA-seq of keratoconus patient samples","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — gain- and loss-of-function with pathway readout, in vitro and in vivo confirmation, single lab","pmids":["39652089"],"is_preprint":false}],"current_model":"ALDH3A1 is a cytosolic NAD(P)+-dependent aldehyde dehydrogenase that is highly abundant in mammalian cornea, stomach, and lung; it preferentially oxidizes medium-chain (≥C6) toxic aldehydes—especially 4-hydroxy-2-nonenal generated by lipid peroxidation—to their corresponding carboxylic acids, generating NADPH in the process, and thereby protects cells from oxidative stress-induced apoptosis, protein adduct formation, and glutathione depletion; beyond its enzymatic role, ALDH3A1 acts as a UV-absorbing corneal crystallin, exhibits chaperone-like activity, inhibits corneal epithelial proliferation partly via p53 nuclear sequestration, and its degradation is controlled by the ubiquitin ligase FBXL12 to regulate trophoblast differentiation; its expression is transcriptionally governed upstream by AhR/XRE and NRF2/EpRE elements as well as by TP63 super-enhancer activity in squamous cancers, placing it at the intersection of redox defense, ferroptosis resistance, circadian clock signaling, and cancer chemoresistance."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing the transcriptional control of ALDH3A1: the question of how ALDH3A1 expression is induced by xenobiotics was answered by identifying multiple cooperative AhR-responsive elements in the promoter, placing the gene squarely in the dioxin/xenobiotic-response pathway.","evidence":"Promoter deletion/reporter constructs and AhR-dependency assays in Hepa-1c1c7 mouse hepatoma cells","pmids":["10591537"],"confidence":"High","gaps":["Whether NRF2/EpRE and AhR elements cooperate at the endogenous locus was not tested","Chromatin-level regulation not examined","Tissue-specific transcriptional mechanisms not addressed"]},{"year":1999,"claim":"Natural allelic variants in the mouse Aldh3a1c allele revealed that structural integrity of the Rossmann fold and a conserved β-strand are critical for enzymatic activity, since four substitutions abolished activity without altering mRNA levels.","evidence":"Sequencing of ALDH3A1 cDNA from multiple inbred mouse strains with enzymatic activity assays across tissues","pmids":["10376761"],"confidence":"Medium","gaps":["Variants were not reconstituted individually in recombinant systems to assign causality to each substitution","Structural basis inferred from sequence analysis, not crystal structure"]},{"year":2001,"claim":"The cellular protective function of ALDH3A1 against lipid peroxidation-derived aldehydes was established: overexpression prevented aldehyde-induced glutathione depletion, protein adduct formation, and apoptosis, defining ALDH3A1 as an anti-apoptotic aldehyde scavenger.","evidence":"Stable transfection of ALDH3A1 in V79 and RAW 264.7 cells with viability, glutathione, adduct, and apoptosis assays","pmids":["11306050"],"confidence":"High","gaps":["Endogenous loss-of-function not yet tested at this point","Relative contribution to total cellular aldehyde metabolism not quantified"]},{"year":2003,"claim":"Biochemical characterization of recombinant ALDH3A1 defined its substrate specificity as strongly favoring medium-chain (≥C6) aldehydes including 4-HNE, while excluding short-chain aldehydes and sugar phosphates, resolving the enzyme's metabolic niche.","evidence":"Recombinant protein expressed in Sf9 cells, purified and assayed with comprehensive substrate panel","pmids":["12943535"],"confidence":"High","gaps":["In vivo substrate confirmation not performed at this stage","Cofactor preference (NAD⁺ vs. NADP⁺) kinetics not fully dissected"]},{"year":2003,"claim":"UV radiation was shown to inactivate ALDH3A1 through post-translational aggregation rather than direct active-site damage, establishing that ALDH3A1 acts as a sacrificial UV absorber in the cornea.","evidence":"In vivo UV exposure of C57BL/6J mouse corneas; in vitro UV irradiation of recombinant ALDH3A1 and stably transfected HCE cells with spectroscopic and aggregation analyses","pmids":["12604188","21203538"],"confidence":"High","gaps":["Turnover and replacement kinetics of UV-damaged ALDH3A1 in vivo not determined","Whether aggregated ALDH3A1 retains chaperone function unknown"]},{"year":2006,"claim":"ALDH3A1 was shown to protect other enzymes from aldehyde-mediated inactivation and to absorb UVB shielding partner proteins; additionally, a structural transition near physiological temperature suggested intrinsic chaperone-like activity, expanding the functional repertoire beyond catalysis.","evidence":"In vitro co-incubation of recombinant ALDH3A1 with G6PDH under aldehyde/UV stress, spectroscopic structural analysis","pmids":["17158879"],"confidence":"High","gaps":["Chaperone activity not yet demonstrated with dedicated chaperone assay clients","In vivo relevance of chaperone function not established"]},{"year":2007,"claim":"Genetic loss-of-function in vivo proved ALDH3A1's physiological importance: Aldh3a1-knockout mice developed cataracts with elevated protein oxidation and lipid aldehyde adducts, demonstrating that ALDH3A1 is essential for lens and corneal transparency through both enzymatic detoxification and UV absorption.","evidence":"Single and double (Aldh1a1/Aldh3a1) knockout mice with slit-lamp exam, histology, proteasome activity, protein carbonylation, and 4-HNE/MDA adduct measurements","pmids":["17567582"],"confidence":"High","gaps":["Relative contributions of enzymatic vs. crystallin/UV-filter functions not separated in vivo","Corneal vs. lens-specific effects not fully delineated"]},{"year":2014,"claim":"Crystal structures of ALDH3A1 with selective inhibitors CB7 and CB29 mapped the aldehyde-binding pocket and enabled isoenzyme-selective pharmacology, demonstrating that ALDH3A1 inhibition sensitizes cancer cells to alkylating chemotherapy.","evidence":"X-ray crystallography, kinetic and mutagenesis studies, isoenzyme selectivity panels, mafosfamide sensitization assays in A549 and SF767 cells","pmids":["24387105","24677340"],"confidence":"High","gaps":["In vivo chemosensitization not tested with these inhibitors","Structural basis for cofactor selectivity not resolved"]},{"year":2015,"claim":"FBXL12 was identified as the E3 ubiquitin ligase that targets ALDH3A1 for proteasomal degradation, and accumulation of ALDH3A1 in FBXL12-knockout placenta impaired trophoblast differentiation, revealing a developmental role for ALDH3A1 protein turnover.","evidence":"Co-immunoprecipitation, ubiquitylation assays, FBXL12-KO mice, trophoblast stem cell differentiation assays with forced ALDH3A1 expression","pmids":["26124079"],"confidence":"High","gaps":["Whether FBXL12 regulation of ALDH3A1 operates in cornea or lung tissues unknown","Degron motif on ALDH3A1 not identified"]},{"year":2015,"claim":"Pharmacological expansion of ALDH3A1's substrate range was demonstrated: the small molecule Alda-89 enabled ALDH3A1 to metabolize acetaldehyde, reducing blood ethanol/acetaldehyde levels in mice, showing that ALDH3A1 can be therapeutically redirected.","evidence":"In vitro enzymatic assay and in vivo mouse models (wild-type and ALDH2*1/*2 knock-in) with blood alcohol/aldehyde measurement","pmids":["25713355"],"confidence":"High","gaps":["Structural mechanism by which Alda-89 alters substrate acceptance not resolved","Long-term safety of ALDH3A1 substrate redirection not assessed"]},{"year":2016,"claim":"Dissection of enzymatic vs. non-enzymatic functions revealed that wild-type but not catalytically inactive ALDH3A1 promotes p53 nuclear sequestration and suppresses corneal epithelial proliferation, while DKO mice show corneal hyperproliferation with p53 loss.","evidence":"Tet-inducible wild-type and catalytic-mutant ALDH3A1 cell lines, proliferation assays, p53 nuclear fractionation, Aldh1a1/3a1 DKO mouse corneal analysis","pmids":["26751691"],"confidence":"High","gaps":["Molecular mechanism linking ALDH3A1 catalytic activity to p53 nuclear retention unknown","Whether a metabolic product mediates the p53 effect not tested"]},{"year":2017,"claim":"Formal demonstration of ALDH3A1's chaperone activity was achieved: recombinant protein protected SmaI and citrate synthase from thermal inactivation in vitro, and overexpression in E. coli and corneal cells conferred stress resistance independent of catalysis.","evidence":"In vitro chaperone assays with multiple client proteins, E. coli thermal shock, HCE-2 cell oxidative stress assays","pmids":["28526614"],"confidence":"High","gaps":["Whether chaperone and catalytic functions are structurally separable not resolved","Client specificity in vivo not defined"]},{"year":2018,"claim":"ALDH3A1 was placed at the nexus of cancer chemoresistance through multiple signaling axes: downstream of PER2 circadian regulation and Wnt/β-catenin signaling, and as a mediator of resistance to glutathione depletion-induced cell death via 4-HNE detoxification in HNSCC.","evidence":"shRNA knockdown in Per2-mutant fibroblasts and GBM cells with chemosensitivity/ROS assays; pharmacological Wnt inhibition; shRNA in sulfasalazine-resistant HNSCC with 4-HNE measurement and in vivo tumor assays","pmids":["30429219","29854309","30333913"],"confidence":"Medium","gaps":["Direct transcriptional regulation by PER2 or β-catenin on ALDH3A1 promoter not confirmed by ChIP","Whether these pathways converge on shared regulatory elements unknown","Single-lab findings for each axis"]},{"year":2018,"claim":"Chemoproteomics identified the catalytic cysteine as the site of covalent inhibitor EN40 binding, and EN40 impaired lung cancer growth in vivo, validating ALDH3A1 as a druggable cancer target.","evidence":"Activity-based protein profiling in NSCLC cells, covalent ligand screen, in vitro and in vivo xenograft validation","pmids":["30004670"],"confidence":"High","gaps":["Selectivity profile of EN40 across full ALDH superfamily not complete","Mechanism of anti-proliferative effect beyond ALDH3A1 inhibition not excluded"]},{"year":2020,"claim":"CRISPR-knockout zebrafish confirmed 4-HNE as the primary in vivo substrate of Aldh3a1 and revealed an unexpected role in glucose homeostasis, linking lipid aldehyde detoxification to pancreatic function.","evidence":"aldh3a1-null zebrafish with transgenic reporters, metabolomics, reactive carbonyl species measurement, transcriptomics","pmids":["32980661"],"confidence":"High","gaps":["Mechanism linking 4-HNE accumulation to pancreatic disruption not molecularly defined","Whether mammalian ALDH3A1 has a similar metabolic role unknown"]},{"year":2024,"claim":"ALDH3A1 was identified as a mechanosensitive gene in corneal keratocytes: mechanical strain upregulates ALDH3A1, which inhibits NF-κB nuclear translocation to suppress proliferation and migration, linking biomechanical cues to ALDH3A1's anti-proliferative function.","evidence":"Flexcell tension system, RNAi, NF-κB immunofluorescence, BrdU proliferation, scratch wound, mouse injury models, scRNA-seq of keratoconus samples","pmids":["39652089"],"confidence":"Medium","gaps":["Mechanotransduction pathway from strain to ALDH3A1 transcription not identified","Whether the NF-κB inhibition depends on catalytic activity or protein–protein interaction unknown"]},{"year":2025,"claim":"TP63 super-enhancer binding was shown to drive high ALDH3A1 expression in squamous cell carcinomas, and ALDH3A1 enzymatic activity was demonstrated to protect specifically against ferroptosis by mitigating lipid peroxidation-derived aldehydes.","evidence":"ChIP-seq, EN40 covalent inhibitor, viability assays, organoid models, xenograft, lipid peroxidation measurement","pmids":["39863749"],"confidence":"Medium","gaps":["Whether ALDH3A1 is the primary or sole effector of TP63-driven ferroptosis resistance not excluded","Specific aldehyde substrates mediating ferroptosis protection not identified"]},{"year":2026,"claim":"Dietary isothiocyanates were shown to irreversibly inhibit ALDH3A1 by forming a covalent adduct at the catalytic Cys243, disrupting aldehyde metabolism in saliva—establishing a physiologically relevant environmental inhibitor of ALDH3A1.","evidence":"X-ray crystallography, mass spectrometry, enzymatic assays, ex vivo saliva assays, GC-MS aroma analysis","pmids":["41672019"],"confidence":"High","gaps":["Systemic consequences of dietary ALDH3A1 inhibition beyond salivary function not explored","Whether chronic isothiocyanate exposure affects corneal or lung ALDH3A1 unknown"]},{"year":null,"claim":"Key unresolved questions include the molecular mechanism by which ALDH3A1 catalytic activity promotes p53 nuclear retention, the structural basis for its chaperone function and whether it can be genetically separated from catalysis, the identity of specific aldehyde products that mediate its anti-ferroptotic and anti-proliferative effects, and whether its metabolic roles in glucose homeostasis observed in zebrafish extend to mammals.","evidence":"","pmids":[],"confidence":"Low","gaps":["Mechanism of p53 nuclear sequestration by ALDH3A1 unknown","Chaperone vs. catalytic domains not structurally separated","Mammalian relevance of glucose homeostasis phenotype unconfirmed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,3,6,9,20,26]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[4,11]},{"term_id":"GO:0016209","term_label":"antioxidant activity","supporting_discovery_ids":[1,2,3,5,6,20]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,2,6]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,9,20,28]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,2,3,5,6,11,17]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,2,3,22]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,29]}],"complexes":[],"partners":["FBXL12","TP63","NRF2","AHR","TP53"],"other_free_text":[]},"mechanistic_narrative":"ALDH3A1 is a cytosolic NAD(P)⁺-dependent aldehyde dehydrogenase that serves as a central detoxification enzyme for medium-chain and lipid peroxidation-derived aldehydes—particularly 4-hydroxynonenal (4-HNE)—and functions as a corneal crystallin with UV-absorbing and chaperone-like properties. The enzyme preferentially oxidizes aldehydes of ≥6 carbons to their corresponding carboxylic acids, thereby preventing 4-HNE–protein adduct formation, glutathione depletion, proteasome dysfunction, and apoptosis triggered by oxidative stress, UV radiation, and cytotoxic drugs [PMID:12943535, PMID:11306050, PMID:22406320]; Aldh3a1-knockout mice develop cataracts with elevated protein oxidation and lipid aldehyde adducts, and aldh3a1-null zebrafish accumulate 4-HNE and display hyperglycemia, confirming in vivo protective roles [PMID:17567582, PMID:32980661]. Beyond catalysis, ALDH3A1 exhibits molecular chaperone activity protecting enzymes from thermal inactivation, regulates corneal epithelial proliferation partly by promoting p53 nuclear sequestration through an enzymatic-activity-dependent mechanism, and its turnover is controlled by the ubiquitin ligase FBXL12 to regulate trophoblast differentiation [PMID:28526614, PMID:26751691, PMID:26124079]. Transcriptionally, ALDH3A1 is induced through AhR/XRE elements, NRF2 signaling, and TP63 super-enhancer binding in squamous cancers, where its enzymatic activity confers resistance to ferroptosis, chemotherapeutic agents, and glutathione depletion-induced cell death [PMID:10591537, PMID:28671577, PMID:39863749, PMID:30333913]."},"prefetch_data":{"uniprot":{"accession":"P30838","full_name":"Aldehyde dehydrogenase, dimeric NADP-preferring","aliases":["ALDHIII","Aldehyde dehydrogenase 3","Aldehyde dehydrogenase family 3 member A1"],"length_aa":453,"mass_kda":50.4,"function":"ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde (Probable). They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation (Probable). Oxidizes medium and long chain aldehydes into non-toxic fatty acids (PubMed:1737758). Preferentially oxidizes aromatic aldehyde substrates (PubMed:1737758). Comprises about 50 percent of corneal epithelial soluble proteins (By similarity). May play a role in preventing corneal damage caused by ultraviolet light (By similarity)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P30838/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ALDH3A1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ALDH3A1","total_profiled":1310},"omim":[{"mim_id":"100660","title":"ALDEHYDE DEHYDROGENASE, FAMILY 3, SUBFAMILY A, MEMBER 1; ALDH3A1","url":"https://www.omim.org/entry/100660"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"esophagus","ntpm":504.2},{"tissue":"salivary gland","ntpm":117.1},{"tissue":"stomach 1","ntpm":212.1}],"url":"https://www.proteinatlas.org/search/ALDH3A1"},"hgnc":{"alias_symbol":[],"prev_symbol":["ALDH3"]},"alphafold":{"accession":"P30838","domains":[{"cath_id":"3.40.605.10","chopping":"4-212_410-430","consensus_level":"high","plddt":98.6847,"start":4,"end":430},{"cath_id":"3.40.309.10","chopping":"217-396","consensus_level":"high","plddt":98.6819,"start":217,"end":396}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30838","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30838-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30838-F1-predicted_aligned_error_v6.png","plddt_mean":97.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ALDH3A1","jax_strain_url":"https://www.jax.org/strain/search?query=ALDH3A1"},"sequence":{"accession":"P30838","fasta_url":"https://rest.uniprot.org/uniprotkb/P30838.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30838/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30838"}},"corpus_meta":[{"pmid":"17920722","id":"PMC_17920722","title":"ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.","date":"2007","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/17920722","citation_count":172,"is_preprint":false},{"pmid":"11914911","id":"PMC_11914911","title":"Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.","date":"2002","source":"Cancer chemotherapy and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11914911","citation_count":164,"is_preprint":false},{"pmid":"17567582","id":"PMC_17567582","title":"Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17567582","citation_count":154,"is_preprint":false},{"pmid":"12943535","id":"PMC_12943535","title":"Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12943535","citation_count":138,"is_preprint":false},{"pmid":"16797007","id":"PMC_16797007","title":"ALDH3A1: a corneal crystallin with diverse functions.","date":"2006","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/16797007","citation_count":121,"is_preprint":false},{"pmid":"18496131","id":"PMC_18496131","title":"Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.","date":"2008","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18496131","citation_count":109,"is_preprint":false},{"pmid":"12706498","id":"PMC_12706498","title":"Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage.","date":"2003","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12706498","citation_count":99,"is_preprint":false},{"pmid":"11306050","id":"PMC_11306050","title":"Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11306050","citation_count":73,"is_preprint":false},{"pmid":"30333913","id":"PMC_30333913","title":"Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30333913","citation_count":69,"is_preprint":false},{"pmid":"28671577","id":"PMC_28671577","title":"Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.","date":"2017","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28671577","citation_count":64,"is_preprint":false},{"pmid":"24387105","id":"PMC_24387105","title":"Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.","date":"2014","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24387105","citation_count":62,"is_preprint":false},{"pmid":"4073832","id":"PMC_4073832","title":"Chromosome assignment, biochemical and immunological studies on a human aldehyde dehydrogenase, ALDH3.","date":"1985","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/4073832","citation_count":58,"is_preprint":false},{"pmid":"32297178","id":"PMC_32297178","title":"Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis.","date":"2020","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32297178","citation_count":56,"is_preprint":false},{"pmid":"17023273","id":"PMC_17023273","title":"Antioxidant function of corneal ALDH3A1 in cultured stromal fibroblasts.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17023273","citation_count":55,"is_preprint":false},{"pmid":"29854309","id":"PMC_29854309","title":"Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29854309","citation_count":52,"is_preprint":false},{"pmid":"17158879","id":"PMC_17158879","title":"Mechanisms involved in the protection of UV-induced protein inactivation by the corneal crystallin ALDH3A1.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17158879","citation_count":51,"is_preprint":false},{"pmid":"25713355","id":"PMC_25713355","title":"Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25713355","citation_count":51,"is_preprint":false},{"pmid":"24677340","id":"PMC_24677340","title":"Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.","date":"2014","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/24677340","citation_count":50,"is_preprint":false},{"pmid":"31817719","id":"PMC_31817719","title":"ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31817719","citation_count":48,"is_preprint":false},{"pmid":"16716894","id":"PMC_16716894","title":"Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression.","date":"2006","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16716894","citation_count":47,"is_preprint":false},{"pmid":"37730658","id":"PMC_37730658","title":"Hypoxia-induced ALDH3A1 promotes the proliferation of non-small-cell lung cancer by regulating energy metabolism reprogramming.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37730658","citation_count":45,"is_preprint":false},{"pmid":"32980661","id":"PMC_32980661","title":"Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32980661","citation_count":45,"is_preprint":false},{"pmid":"22406320","id":"PMC_22406320","title":"Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal.","date":"2012","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22406320","citation_count":43,"is_preprint":false},{"pmid":"30004670","id":"PMC_30004670","title":"Chemoproteomics-Enabled Covalent Ligand Screening Reveals ALDH3A1 as a Lung Cancer Therapy Target.","date":"2018","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30004670","citation_count":41,"is_preprint":false},{"pmid":"10591537","id":"PMC_10591537","title":"Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression.","date":"1999","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10591537","citation_count":38,"is_preprint":false},{"pmid":"12604188","id":"PMC_12604188","title":"Ultraviolet radiation decreases expression and induces aggregation of corneal ALDH3A1.","date":"2003","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/12604188","citation_count":36,"is_preprint":false},{"pmid":"8363638","id":"PMC_8363638","title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain.","date":"1993","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8363638","citation_count":34,"is_preprint":false},{"pmid":"23451057","id":"PMC_23451057","title":"Efficient E. coli expression strategies for production of soluble human crystallin ALDH3A1.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23451057","citation_count":31,"is_preprint":false},{"pmid":"21203538","id":"PMC_21203538","title":"Structural and functional modifications of corneal crystallin ALDH3A1 by UVB light.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21203538","citation_count":27,"is_preprint":false},{"pmid":"8607142","id":"PMC_8607142","title":"Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD).","date":"1996","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/8607142","citation_count":27,"is_preprint":false},{"pmid":"24276407","id":"PMC_24276407","title":"ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway.","date":"2013","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24276407","citation_count":24,"is_preprint":false},{"pmid":"26751691","id":"PMC_26751691","title":"ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26751691","citation_count":24,"is_preprint":false},{"pmid":"10376761","id":"PMC_10376761","title":"Four amino acid changes are associated with the Aldh3a1 locus polymorphism in mice which may be responsible for corneal sensitivity to ultraviolet light.","date":"1999","source":"Pharmacogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10376761","citation_count":23,"is_preprint":false},{"pmid":"30429219","id":"PMC_30429219","title":"Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30429219","citation_count":23,"is_preprint":false},{"pmid":"33294267","id":"PMC_33294267","title":"Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.","date":"2020","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33294267","citation_count":22,"is_preprint":false},{"pmid":"34234849","id":"PMC_34234849","title":"ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34234849","citation_count":18,"is_preprint":false},{"pmid":"11306049","id":"PMC_11306049","title":"Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11306049","citation_count":17,"is_preprint":false},{"pmid":"26124079","id":"PMC_26124079","title":"FBXL12-Mediated Degradation of ALDH3 is Essential for Trophoblast Differentiation During Placental Development.","date":"2015","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/26124079","citation_count":16,"is_preprint":false},{"pmid":"8979087","id":"PMC_8979087","title":"The human aldehyde dehydrogenase 3 gene (ALDH3): identification of a new exon and diverse mRNA isoforms, and functional analysis of the promoter.","date":"1996","source":"Gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/8979087","citation_count":16,"is_preprint":false},{"pmid":"21296057","id":"PMC_21296057","title":"Comparative studies of vertebrate aldehyde dehydrogenase 3: sequences, structures, phylogeny and evolution. Evidence for a mammalian origin for the ALDH3A1 gene.","date":"2011","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/21296057","citation_count":15,"is_preprint":false},{"pmid":"15547490","id":"PMC_15547490","title":"Alkali burn causes aldehyde dehydrogenase 3A1 (ALDH3A1) decrease in mouse cornea.","date":"2004","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/15547490","citation_count":15,"is_preprint":false},{"pmid":"28038895","id":"PMC_28038895","title":"Corneal haze phenotype in Aldh3a1-null mice: In vivo confocal microscopy and tissue imaging mass spectrometry.","date":"2016","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/28038895","citation_count":15,"is_preprint":false},{"pmid":"35188323","id":"PMC_35188323","title":"ALDH3A1 overexpression in OSCC inhibits inflammation via phospho-Ser727 at STAT3 in tumor-associated macrophages.","date":"2022","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35188323","citation_count":15,"is_preprint":false},{"pmid":"28526614","id":"PMC_28526614","title":"Human aldehyde dehydrogenase 3A1 (ALDH3A1) exhibits chaperone-like function.","date":"2017","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28526614","citation_count":14,"is_preprint":false},{"pmid":"21251908","id":"PMC_21251908","title":"Importance of inverse correlation between ALDH3A1 and PPARγ in tumor cells and tissue regeneration.","date":"2011","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/21251908","citation_count":13,"is_preprint":false},{"pmid":"8761421","id":"PMC_8761421","title":"Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).","date":"1996","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8761421","citation_count":13,"is_preprint":false},{"pmid":"11121727","id":"PMC_11121727","title":"Changes of CYP1A1, GST, and ALDH3 enzymes in hepatoma cell lines undergoing enhanced lipid peroxidation.","date":"2000","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11121727","citation_count":12,"is_preprint":false},{"pmid":"1859355","id":"PMC_1859355","title":"Aldehyde dehydrogenase (ALDH) isozymes in the gray short-tailed opossum (Monodelphis domestica): tissue and subcellular distribution and biochemical genetics of ALDH3.","date":"1991","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1859355","citation_count":12,"is_preprint":false},{"pmid":"12604189","id":"PMC_12604189","title":"Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1.","date":"2003","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/12604189","citation_count":12,"is_preprint":false},{"pmid":"27976863","id":"PMC_27976863","title":"Development of Highly Selective Fluorescent Probe Enabling Flow-Cytometric Isolation of ALDH3A1-Positive Viable Cells.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27976863","citation_count":11,"is_preprint":false},{"pmid":"38225738","id":"PMC_38225738","title":"ALDH3A1 upregulation inhibits neutrophils N2 polarization and halts oral cancer growth.","date":"2024","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/38225738","citation_count":10,"is_preprint":false},{"pmid":"17151192","id":"PMC_17151192","title":"Constitutive and 3-methylcholanthrene-induced rat ALDH3A1 expression is mediated by multiple xenobiotic response elements.","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17151192","citation_count":10,"is_preprint":false},{"pmid":"12604185","id":"PMC_12604185","title":"An algorithm for identification and ranking of family-specific residues, applied to the ALDH3 family.","date":"2003","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/12604185","citation_count":10,"is_preprint":false},{"pmid":"33596621","id":"PMC_33596621","title":"Association with Corneal Remodeling Related Genes, ALDH3A1, LOX, and SPARC Genes Variations in Korean Keratoconus Patients.","date":"2021","source":"Korean journal of ophthalmology : KJO","url":"https://pubmed.ncbi.nlm.nih.gov/33596621","citation_count":8,"is_preprint":false},{"pmid":"39863749","id":"PMC_39863749","title":"Targeting aldehyde dehydrogenase ALDH3A1 increases ferroptosis vulnerability in squamous cancer.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/39863749","citation_count":5,"is_preprint":false},{"pmid":"35011749","id":"PMC_35011749","title":"Common ALDH3A1 Gene Variant Associated with Keratoconus Risk in the Polish Population.","date":"2021","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35011749","citation_count":5,"is_preprint":false},{"pmid":"11306038","id":"PMC_11306038","title":"Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11306038","citation_count":5,"is_preprint":false},{"pmid":"19894643","id":"PMC_19894643","title":"The oxidation status of ALDH3A1 in human saliva and its correlation with antioxidant capacity measured by ORAC method.","date":"2009","source":"Acta poloniae pharmaceutica","url":"https://pubmed.ncbi.nlm.nih.gov/19894643","citation_count":5,"is_preprint":false},{"pmid":"32493941","id":"PMC_32493941","title":"Generation and characterization of Aldh3-Cre transgenic mice as a tool for conditional gene deletion in postnatal cornea.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32493941","citation_count":4,"is_preprint":false},{"pmid":"38191346","id":"PMC_38191346","title":"Chronic restraint stress promotes oral squamous cell carcinoma development by inhibiting ALDH3A1 via stress response hormone.","date":"2024","source":"BMC oral health","url":"https://pubmed.ncbi.nlm.nih.gov/38191346","citation_count":4,"is_preprint":false},{"pmid":"11672702","id":"PMC_11672702","title":"Inhibition of ALDH3A1-catalyzed oxidation by chlorpropamide analogues.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11672702","citation_count":4,"is_preprint":false},{"pmid":"11306048","id":"PMC_11306048","title":"Effects of 3-methylcholanthrene and aspirin co-administration on ALDH3A1 in HepG2 cells.","date":"2001","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/11306048","citation_count":4,"is_preprint":false},{"pmid":"37021113","id":"PMC_37021113","title":"Identification of a peptide ligand for human ALDH3A1 through peptide phage display: Prediction and characterization of protein interaction sites and inhibition of ALDH3A1 enzymatic activity.","date":"2023","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/37021113","citation_count":4,"is_preprint":false},{"pmid":"39652089","id":"PMC_39652089","title":"Corneal strain influences keratocyte proliferation and migration through upregulation of ALDH3A1 expression.","date":"2024","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/39652089","citation_count":2,"is_preprint":false},{"pmid":"41046948","id":"PMC_41046948","title":"Aldehyde dehydrogenase ALDH3A1 rescues cigarette smoke-induced emphysema by conferring alveolar type 2 to type 1 cell transition.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41046948","citation_count":1,"is_preprint":false},{"pmid":"41327788","id":"PMC_41327788","title":"Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction.","date":"2025","source":"Redox report : communications in free radical research","url":"https://pubmed.ncbi.nlm.nih.gov/41327788","citation_count":1,"is_preprint":false},{"pmid":"41513604","id":"PMC_41513604","title":"ALDH3A1-dependent Nrf2/HO-1/GPX4 pathway supports AHR as a promising therapeutic target for ferroptosis and promotes imperatorin-mediated lung protection.","date":"2026","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41513604","citation_count":0,"is_preprint":false},{"pmid":"41564796","id":"PMC_41564796","title":"A viral-host redox axis: EBNA1-FOSL2-ALDH3A1 defines a targetable vulnerability in EBV-positive carcinomas.","date":"2026","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/41564796","citation_count":0,"is_preprint":false},{"pmid":"39677625","id":"PMC_39677625","title":"ALDH3A1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to denervation and Amyotrophic Lateral Sclerosis progression.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39677625","citation_count":0,"is_preprint":false},{"pmid":"40825534","id":"PMC_40825534","title":"Sad from Proteobacteria is a Structurally Distinct ALDH3 Enzyme Specialized for the Oxidation of Steroidal Aldehydes.","date":"2025","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40825534","citation_count":0,"is_preprint":false},{"pmid":"41672019","id":"PMC_41672019","title":"Dietary isothiocyanates inhibit the oxidative activity of salivary aldehyde dehydrogenase ALDH3A1 and modulate aroma release.","date":"2026","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41672019","citation_count":0,"is_preprint":false},{"pmid":"41724003","id":"PMC_41724003","title":"Novel benzophenones from the fibrous roots of Anemarrhena asphodeloides Bunge inhibit hepatocellular carcinoma activity by targeting ALDH3A1.","date":"2026","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41724003","citation_count":0,"is_preprint":false},{"pmid":"40657474","id":"PMC_40657474","title":"Association of ALDH3A1 expression with tumor differentiation, pathological stage, and nodal status in oral squamous cell carcinoma.","date":"2025","source":"Journal of Taibah University Medical Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40657474","citation_count":0,"is_preprint":false},{"pmid":"41831802","id":"PMC_41831802","title":"Aldh3a1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to amyotrophic lateral sclerosis progression.","date":"2026","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41831802","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.13.688345","title":"Genotoxic formaldehyde and lipid aldehydes are sources of DNA damage in keratinocytes","date":"2025-11-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.13.688345","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.01.668186","title":"A Sequence Motif Enables Widespread Use of Non-Canonical Redox Cofactors in Natural Enzymes","date":"2025-08-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.01.668186","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43115,"output_tokens":8204,"usd":0.126202},"stage2":{"model":"claude-opus-4-6","input_tokens":12010,"output_tokens":4737,"usd":0.267713},"total_usd":0.393915,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Human ALDH3A1 expressed in Sf9 insect cells and purified demonstrates high substrate specificity for medium-chain (≥6 carbon) saturated and unsaturated aldehydes including 4-hydroxy-2-nonenal (4-HNE), while short-chain aldehydes (acetaldehyde, propionaldehyde, malondialdehyde) are very poor substrates; glyceraldehyde is metabolized poorly and glucose-6-phosphate, 6-phosphoglucono-delta-lactone, and 6-phosphogluconate are not metabolized at all.\",\n      \"method\": \"Recombinant protein expression in Sf9 cells, affinity chromatography purification, in vitro enzymatic assays with defined substrates\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted recombinant enzyme with comprehensive substrate panel, multiple orthogonal methods\",\n      \"pmids\": [\"12943535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Stable transfection of human ALDH3A1 in V79 cells confers protection against growth inhibition and apoptosis induced by medium-chain aldehydes (hexanal, trans-2-hexenal, trans-2-octenal, trans-2-nonenal, 4-HNE) by oxidizing them to their corresponding carboxylic acids, preventing glutathione depletion and protein adduct formation; ALDH3A1 completely blocked HNE-induced apoptosis in both V79 and RAW 264.7 macrophage cells.\",\n      \"method\": \"Stable transfection, cell viability assays, glutathione measurement, protein adduct detection, apoptosis assays, in vitro enzymatic assays with crude cytosol\",\n      \"journal\": \"Chemico-biological interactions\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, two cell line systems, mechanistic follow-up with substrate specificity\",\n      \"pmids\": [\"11306050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Stable transfection of ALDH3A1 in human corneal epithelial cells (HCE) protects against UV- and 4-HNE-induced cytotoxicity and apoptosis (via caspase-3/PARP pathway); ALDH3A1-expressing cells had 50% higher NAD(P)H levels upon 4-HNE treatment and prevented 4-HNE–protein adduct formation, with a Km for 4-HNE of 54 µM.\",\n      \"method\": \"Stable transfection, UV and 4-HNE cytotoxicity assays, DNA fragmentation assays, caspase-3/PARP Western blot, NAD(P)H measurement, 4-HNE protein adduct detection\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal functional methods in relevant corneal cell line with mechanistic pathway placement\",\n      \"pmids\": [\"12706498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ALDH3A1 stably transfected in rabbit corneal fibroblastic cells (TRK43) protects against H2O2-, mitomycin C-, and etoposide-induced apoptosis and oxidative damage by metabolizing 4-HNE, maintaining glutathione homeostasis, and sustaining redox balance; increased carbonylation of ALDH3A1 occurs after treatment without significant loss of enzymatic activity.\",\n      \"method\": \"Stable transfection, oxidative stress assays, apoptosis detection, GSH measurement, 4-HNE adduct Western blot\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in corneal cell line, multiple stressors tested\",\n      \"pmids\": [\"17023273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ALDH3A1 protects glucose-6-phosphate dehydrogenase (G6PDH) from inactivation by 4-HNE and malondialdehyde when co-incubated with NADP+, demonstrating enzymatic protection of other proteins; at large excess, ALDH3A1 directly absorbs UVB and shields G6PDH from UV inactivation. ALDH3A1 also undergoes a structural transition near physiological temperatures to a partially unfolded conformation suggestive of chaperone activity.\",\n      \"method\": \"In vitro co-incubation assays with recombinant proteins, G6PDH activity measurements, UV exposure experiments, spectroscopic analysis of structural transitions\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with mechanistic controls, multiple protective mechanisms demonstrated\",\n      \"pmids\": [\"17158879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Aldh3a1−/− and Aldh1a1−/−/Aldh3a1−/− double knockout mice develop cataracts (anterior and posterior subcapsular and punctate cortical opacities) by 1 month of age; UVB exposure accelerates anterior lens opacification more in Aldh3a1−/− mice; cataract formation is associated with decreased proteasomal activity, increased protein oxidation, and increased 4-HNE and malondialdehyde-protein adducts, demonstrating that ALDH3A1 protects against cataract through both enzymatic and non-enzymatic (light-filtering) functions.\",\n      \"method\": \"Single and double knockout mouse models, UVB exposure, slit-lamp/histological evaluation, proteasome activity assay, protein carbonylation assay, 4-HNE/MDA adduct Western blots, GSH measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous in vivo genetic loss-of-function with multiple biochemical readouts, two single and one double KO line\",\n      \"pmids\": [\"17567582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ALDH3A1 overexpression in TRK43 corneal keratocyte cells protects from 4-HNE-induced cytotoxicity by metabolizing 4-HNE and its glutathione conjugate, preventing 4-HNE–protein adduct formation, blocking apoptosis, maintaining glutathione homeostasis, and preserving proteasome function.\",\n      \"method\": \"Stable transfection, cell viability assays, morphological evaluation, Western blot for 4-HNE adducts, glutathione assay, proteasome activity assay, apoptosis assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mechanistic readouts in corneal cell line\",\n      \"pmids\": [\"22406320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystallographic and kinetic studies of ALDH3A1 with selective inhibitor CB7 (1-[(4-fluorophenyl)sulfonyl]-2-methyl-1H-benzimidazole, IC50 0.2 µM) show that CB7 binds within the aldehyde-binding pocket of ALDH3A1; mutagenesis confirmed this binding site; CB7 does not inhibit ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, or ALDH2. ALDH3A1-expressing lung adenocarcinoma (A549) and glioblastoma (SF767) cells are sensitized to mafosfamide by CB7, whereas fibroblasts lacking ALDH3A1 are not.\",\n      \"method\": \"X-ray crystallography, kinetic inhibition assays, active-site mutagenesis, isoenzyme selectivity panel, cell proliferation assays with mafosfamide\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis and kinetics, orthogonal cellular validation\",\n      \"pmids\": [\"24387105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structure of ALDH3A1 with inhibitor CB29 shows it binds within the aldehyde substrate-binding site; CB29 does not inhibit ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, or ALDH2 at up to 250 µM, confirming isoenzyme selectivity; sensitizes ALDH3A1-expressing tumor cells (A549, SF767) but not ALDH3A1-negative fibroblasts to mafosfamide.\",\n      \"method\": \"X-ray crystallography, kinetic characterization, isoenzyme selectivity assays, cell proliferation assays\",\n      \"journal\": \"Chembiochem : a European journal of chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus kinetics plus cellular functional readout\",\n      \"pmids\": [\"24677340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Small molecule Alda-89 enables ALDH3A1 to metabolize acetaldehyde (a substrate it normally does not accept); when administered with ALDH2 activator Alda-1, Alda-89 reduced blood ethanol and acetaldehyde levels in vivo in wild-type and ALDH2*1/*2 knock-in mice, demonstrating pharmacological recruitment of ALDH3A1 to expand its substrate specificity.\",\n      \"method\": \"In vitro enzymatic assay, in vivo mouse model (wild-type and ALDH2*1/*2 knock-in), blood alcohol/aldehyde measurement, behavioral assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzymatic demonstration plus in vivo validation in two mouse genotypes\",\n      \"pmids\": [\"25713355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Using tetracycline-inducible wild-type and catalytically-inactive ALDH3A1 human corneal epithelial cells (hTCEpi), ALDH3A1 was shown to decrease corneal cell proliferation through both enzymatic and non-enzymatic mechanisms; wild-type but not catalytically-inactive ALDH3A1 promotes p53 nuclear sequestration. In Aldh1a1−/−/Aldh3a1−/− DKO mice, hyperproliferative corneal epithelium shows nearly complete loss of p53 expression.\",\n      \"method\": \"Tet-inducible cell lines expressing wt or catalytically-inactive ALDH3A1, proliferation assays, p53 nuclear fractionation, DKO mouse corneal analysis, differentiation marker mRNA analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — catalytic mutant dissects enzymatic vs. non-enzymatic mechanism, in vitro and in vivo confirmation\",\n      \"pmids\": [\"26751691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Recombinant human ALDH3A1 exhibits molecular chaperone-like activity in vitro: it protects SmaI and citrate synthase from thermal stress-induced precipitation and inactivation; overexpression of ALDH3A1 confers E. coli with enhanced resistance to thermal shock and protects HCE-2 corneal cells from H2O2 and tert-butyl hydroperoxide cytotoxicity.\",\n      \"method\": \"In vitro chaperone assays with recombinant protein and citrate synthase, E. coli thermal shock assays, cell viability assays in corneal cell line\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with multiple client proteins plus cellular confirmation\",\n      \"pmids\": [\"28526614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"UV-light causes soluble, non-native aggregation of ALDH3A1 via covalent and non-covalent interactions, leading to loss of enzymatic activity; MALDI-TOF LysC peptide mapping shows UV-induced modifications to Trp, Met, and Cys residues, but the conserved catalytic Cys remains intact after UV exposure, indicating that inactivation results from structural changes rather than direct active-site damage.\",\n      \"method\": \"UV irradiation of recombinant ALDH3A1, spectroscopic analysis, MALDI-TOF mass spectrometry with LysC peptide mapping, aggregation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro system with mass spectrometric residue-level characterization\",\n      \"pmids\": [\"21203538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Chemoproteomics (activity-based protein profiling) identified the catalytic cysteine of ALDH3A1 as the primary target of the covalent ligand DKM 3-42 in non-small cell lung carcinoma cells; a more selective covalent inhibitor, EN40, inhibits ALDH3A1 activity at this catalytic cysteine and impairs lung cancer cell proliferation in vitro and tumor growth in vivo.\",\n      \"method\": \"Activity-based protein profiling (ABPP), covalent ligand library screen, in vitro cell proliferation assays, in vivo xenograft model\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — chemoproteomic target identification at residue level, in vitro and in vivo functional validation\",\n      \"pmids\": [\"30004670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FBXL12 (F-box and leucine-rich repeat protein 12) interacts specifically with ALDH3-family members including ALDH3A1 and mediates their polyubiquitylation, leading to proteasomal degradation; FBXL12-deficient mice accumulate ALDH3 in the placenta and exhibit impaired trophoblast stem cell differentiation, and forced ALDH3A1 expression in wild-type TSCs phenocopies the differentiation defect.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, FBXL12 knockout mice, TSC differentiation assays, forced overexpression rescue experiments, ALDH inhibitor rescue\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction identified, ubiquitylation demonstrated, KO mouse phenotype, gain-of-function phenocopy, inhibitor rescue\",\n      \"pmids\": [\"26124079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Deletion analysis and transient transfection of 5'-flanking region reporter constructs in mouse hepatoma Hepa-1c1c7 cells show that the Aldh3a1 promoter contains at least four functional aromatic hydrocarbon response elements (AHREs) that act cooperatively for dioxin (TCDD)-mediated induction, a negative regulatory element (NRE) controlling basal expression, and that TCDD-mediated upregulation depends exclusively on the aromatic hydrocarbon receptor (AhR).\",\n      \"method\": \"Promoter deletion/reporter gene (CAT/luciferase) constructs, transient transfection, AhR dependency assay in Hepa-1c1c7 cells\",\n      \"journal\": \"Pharmacogenetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic deletion analysis identifying functional regulatory elements, AhR dependency established\",\n      \"pmids\": [\"10591537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pharmacological Wnt pathway inhibition (LGK974) significantly downregulates ALDH3A1 expression in glioblastoma cells; shRNA-mediated ALDH3A1 knockdown increases TMZ efficacy and reduces clonogenic potential with decreased stem cell markers (CD133, Nestin, Sox2), placing ALDH3A1 downstream of Wnt/β-catenin signaling in glioblastoma chemoresistance.\",\n      \"method\": \"shRNA knockdown, pharmacological Wnt inhibition, transcriptomic analysis, clonogenic assay, proliferation assay, stem cell marker expression\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods but single lab, pathway placement via pharmacological and genetic approaches\",\n      \"pmids\": [\"29854309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In Per2-mutant oncogene-transformed fibroblasts, ALDH3A1 protein is ~7-fold higher than in wild-type transformed cells, correlating with chemoresistance; shRNA knockdown of Aldh3a1 in Per2-mutant cells relieves resistance to methotrexate, gemcitabine, etoposide, vincristine, and oxaliplatin by restoring chemotherapy-induced reactive oxygen species accumulation, placing ALDH3A1 downstream of the PER2 circadian clock component in drug resistance.\",\n      \"method\": \"Per2-mutant mouse embryonic fibroblasts, shRNA knockdown, chemotherapy cytotoxicity assays, ROS measurement, Western blot for ALDH3A1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis via shRNA rescue, ROS mechanism defined, single lab\",\n      \"pmids\": [\"30429219\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Arachidonic acid treatment of A549 lung tumor cells reduces ALDH3A1 enzymatic activity, protein, and mRNA levels, associated with increased PPARγ expression and decreased NF-κB binding; selective PPARγ antagonist GW9662 prevents both ALDH3A1 reduction and A549 cell growth inhibition, identifying PPARγ activation as upstream repressor of ALDH3A1 expression.\",\n      \"method\": \"PPARγ antagonist treatment, ALDH3A1 mRNA/protein/activity measurement, NF-κB binding assay, cell growth assay, vitamin E co-treatment\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis linking PPARγ to ALDH3A1, multiple molecular readouts, single lab\",\n      \"pmids\": [\"16716894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NRF2 knockdown in pancreatic cancer cells markedly reduces ALDH3A1 expression, placing ALDH3A1 transcriptionally downstream of NRF2-mediated antioxidant signaling.\",\n      \"method\": \"siRNA knockdown of NRF2, RT-PCR/Western blot for ALDH3A1 expression, GCLC co-regulation analysis\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single method (siRNA + expression), single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"28671577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"aldh3a1−/− zebrafish generated by CRISPR-Cas9 display retinal vasodilatory alterations and impaired glucose homeostasis; 4-HNE (but not methylglyoxal) was elevated in aldh3a1 mutants, establishing 4-HNE as the primary substrate of Aldh3a1 in vivo and linking impaired 4-HNE detoxification to pancreatic disruption and hyperglycemia.\",\n      \"method\": \"CRISPR-Cas9 knockout zebrafish, transgenic reporter lines for vasculature/pancreas, reactive carbonyl species measurement, transcriptome, metabolomics, ALDH activity assay, pdx1 silencing epistasis\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR knockout with multi-omics and pharmacological rescue, in vivo substrate identification\",\n      \"pmids\": [\"32980661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ALDH3A1 knockdown in sulfasalazine-resistant HNSCC cells sensitizes them to the xCT inhibitor sulfasalazine; dyclonine (a covalent ALDH inhibitor) combined with sulfasalazine induces intracellular 4-HNE accumulation synergistically, demonstrating that ALDH3A1-mediated 4-HNE detoxification is the mechanism of resistance to glutathione depletion-induced cell death.\",\n      \"method\": \"shRNA knockdown, drug combination assays, 4-HNE intracellular measurement, tumor growth assay in vivo\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological convergence on 4-HNE mechanism, in vivo confirmation, single lab\",\n      \"pmids\": [\"30333913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TP63 transcription factor binds to the super-enhancer of ALDH3A1 to drive its high expression in squamous cell carcinomas; ALDH3A1 enzymatic activity (not just protein presence) protects SCC cells against ferroptosis by catalyzing aldehyde oxidation and mitigating lipid peroxidation; the covalent inhibitor EN40 enhances ferroptosis sensitivity.\",\n      \"method\": \"ChIP-seq for TP63 super-enhancer binding, covalent inhibitor EN40, cell viability assays, organoid models, in vivo xenograft, lipid peroxidation measurement\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro and in vivo methods, transcriptional regulation identified, enzymatic dependency shown via specific inhibitor\",\n      \"pmids\": [\"39863749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"UV radiation decreases corneal ALDH3A1 mRNA, protein, and enzymatic activity in C57BL/6J mice; at lower UVB doses, enzymatic activity decreases without transcriptional changes, indicating post-translational modification; in vitro studies with purified recombinant ALDH3A1 and stably transfected HCE cells show UV causes covalent and non-covalent protein aggregation.\",\n      \"method\": \"Northern blot, Western blot, enzymatic activity assay, in vitro UV irradiation of recombinant protein and transfected cell lines\",\n      \"journal\": \"Chemico-biological interactions\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro convergent data identifying post-translational regulation, multiple methods\",\n      \"pmids\": [\"12604188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ALDH3A1 loss in FANCA-deficient keratinocytes causes synthetic lethality with DNA damage marker induction; loss of four functionally redundant ALDH3 isozymes causes lipid aldehyde accumulation; FA-deficient keratinocytes are more sensitive to 4-HNE than FA-competent cells, establishing ALDH3-family enzymes (including ALDH3A1) as a tier-1 defense against lipid aldehyde-induced DNA damage in keratinocytes.\",\n      \"method\": \"Systematic CRISPR/shRNA inactivation of ALDH/ADH genes in FANCA-deficient keratinocyte lines, DNA damage marker assays, 4-HNE sensitivity assays, NAC rescue\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic genetic screen with mechanistic follow-up, but preprint; ALDH3A1 among redundant family members\",\n      \"pmids\": [\"bio_10.1101_2025.11.13.688345\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A conserved RH/QxxR sequence motif in ALDH3A1 (and other ALDH3 family members) enables activity with non-canonical redox cofactor NMN+ (nicotinamide mononucleotide); Bos taurus ALDH3A1 shows unprecedented turnover with NMN+, with kcat values matching or exceeding NAD+; structural analysis shows the motif reinforces cofactor positioning and pre-organizes the active site without requiring the adenosine monophosphate moiety of NAD+.\",\n      \"method\": \"Enzymatic kinetics, X-ray crystallography, molecular dynamics, mutagenesis of the RH/QxxR motif in diverse ALDH scaffolds\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structural and kinetic data with mutagenesis, but preprint\",\n      \"pmids\": [\"bio_10.1101_2025.08.01.668186\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Dietary isothiocyanates (specifically allyl-isothiocyanate) form a covalent adduct with the ALDH3A1 catalytic cysteine residue (Cys243), causing irreversible inhibition of salivary ALDH3A1 activity both in vitro and ex vivo; this inhibition disrupts metabolic conversion of odorant aldehydes in saliva.\",\n      \"method\": \"X-ray crystallography, mass spectrometry adduct identification, in vitro enzymatic assay, ex vivo saliva assays, GC-MS aroma analysis\",\n      \"journal\": \"Food chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure identifying covalent adduct on catalytic Cys243, confirmed by MS and enzymatic assays\",\n      \"pmids\": [\"41672019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Four amino acid substitutions (G88R, I154N, H305R, I352V) in the Aldh3a1c allele of SWR/J mice are responsible for near-complete loss of ALDH3A1 enzymatic activity in all tissues; I154N disrupts a potential alpha helix in the Rossmann fold and H305R affects a beta strand potentially impacting catalytic activity; mRNA levels are unchanged between 'low-activity' and 'high-activity' variants, indicating post-translational/structural basis for activity differences.\",\n      \"method\": \"RT-PCR amplification and sequencing of ALDH3A1 cDNA from multiple inbred mouse strains, enzymatic activity assays across tissues, sequence analysis\",\n      \"journal\": \"Pharmacogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — natural variant analysis with enzymatic confirmation identifying structure-function relationships\",\n      \"pmids\": [\"10376761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ALDH3A1 promotes glycolysis and suppresses oxidative phosphorylation (OXPHOS) in NSCLC cells by activating the HIF-1α/LDHA pathway; its expression is induced by hypoxia; β-elemene downregulates ALDH3A1 to inhibit glycolysis and enhance OXPHOS, suppressing NSCLC proliferation in vitro and in vivo.\",\n      \"method\": \"ALDH3A1 knockdown/overexpression, metabolic flux analysis (glycolysis/OXPHOS), HIF-1α/LDHA pathway analysis, β-elemene treatment, in vivo xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway placement via gain/loss of function with metabolic readouts, in vivo confirmation, single lab\",\n      \"pmids\": [\"37730658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mechanical strain (3%) applied to human keratocytes upregulates ALDH3A1 expression; increased ALDH3A1 inhibits NF-κB nuclear translocation, suppressing keratocyte proliferation and migration; ALDH3A1 knockdown promotes NF-κB nuclear translocation and enhances proliferation and migration, establishing ALDH3A1 as a mechanosensitive regulator of NF-κB signaling in corneal stroma.\",\n      \"method\": \"Flexcell tension system, RT-qPCR, Western blot, RNAi knockdown, NF-κB nuclear translocation immunofluorescence, BrdU proliferation assay, scratch wound healing assay, mouse injury models, single-cell RNA-seq of keratoconus patient samples\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with pathway readout, in vitro and in vivo confirmation, single lab\",\n      \"pmids\": [\"39652089\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ALDH3A1 is a cytosolic NAD(P)+-dependent aldehyde dehydrogenase that is highly abundant in mammalian cornea, stomach, and lung; it preferentially oxidizes medium-chain (≥C6) toxic aldehydes—especially 4-hydroxy-2-nonenal generated by lipid peroxidation—to their corresponding carboxylic acids, generating NADPH in the process, and thereby protects cells from oxidative stress-induced apoptosis, protein adduct formation, and glutathione depletion; beyond its enzymatic role, ALDH3A1 acts as a UV-absorbing corneal crystallin, exhibits chaperone-like activity, inhibits corneal epithelial proliferation partly via p53 nuclear sequestration, and its degradation is controlled by the ubiquitin ligase FBXL12 to regulate trophoblast differentiation; its expression is transcriptionally governed upstream by AhR/XRE and NRF2/EpRE elements as well as by TP63 super-enhancer activity in squamous cancers, placing it at the intersection of redox defense, ferroptosis resistance, circadian clock signaling, and cancer chemoresistance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ALDH3A1 is a cytosolic NAD(P)⁺-dependent aldehyde dehydrogenase that serves as a central detoxification enzyme for medium-chain and lipid peroxidation-derived aldehydes—particularly 4-hydroxynonenal (4-HNE)—and functions as a corneal crystallin with UV-absorbing and chaperone-like properties. The enzyme preferentially oxidizes aldehydes of ≥6 carbons to their corresponding carboxylic acids, thereby preventing 4-HNE–protein adduct formation, glutathione depletion, proteasome dysfunction, and apoptosis triggered by oxidative stress, UV radiation, and cytotoxic drugs [PMID:12943535, PMID:11306050, PMID:22406320]; Aldh3a1-knockout mice develop cataracts with elevated protein oxidation and lipid aldehyde adducts, and aldh3a1-null zebrafish accumulate 4-HNE and display hyperglycemia, confirming in vivo protective roles [PMID:17567582, PMID:32980661]. Beyond catalysis, ALDH3A1 exhibits molecular chaperone activity protecting enzymes from thermal inactivation, regulates corneal epithelial proliferation partly by promoting p53 nuclear sequestration through an enzymatic-activity-dependent mechanism, and its turnover is controlled by the ubiquitin ligase FBXL12 to regulate trophoblast differentiation [PMID:28526614, PMID:26751691, PMID:26124079]. Transcriptionally, ALDH3A1 is induced through AhR/XRE elements, NRF2 signaling, and TP63 super-enhancer binding in squamous cancers, where its enzymatic activity confers resistance to ferroptosis, chemotherapeutic agents, and glutathione depletion-induced cell death [PMID:10591537, PMID:28671577, PMID:39863749, PMID:30333913].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing the transcriptional control of ALDH3A1: the question of how ALDH3A1 expression is induced by xenobiotics was answered by identifying multiple cooperative AhR-responsive elements in the promoter, placing the gene squarely in the dioxin/xenobiotic-response pathway.\",\n      \"evidence\": \"Promoter deletion/reporter constructs and AhR-dependency assays in Hepa-1c1c7 mouse hepatoma cells\",\n      \"pmids\": [\"10591537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF2/EpRE and AhR elements cooperate at the endogenous locus was not tested\", \"Chromatin-level regulation not examined\", \"Tissue-specific transcriptional mechanisms not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Natural allelic variants in the mouse Aldh3a1c allele revealed that structural integrity of the Rossmann fold and a conserved β-strand are critical for enzymatic activity, since four substitutions abolished activity without altering mRNA levels.\",\n      \"evidence\": \"Sequencing of ALDH3A1 cDNA from multiple inbred mouse strains with enzymatic activity assays across tissues\",\n      \"pmids\": [\"10376761\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Variants were not reconstituted individually in recombinant systems to assign causality to each substitution\", \"Structural basis inferred from sequence analysis, not crystal structure\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The cellular protective function of ALDH3A1 against lipid peroxidation-derived aldehydes was established: overexpression prevented aldehyde-induced glutathione depletion, protein adduct formation, and apoptosis, defining ALDH3A1 as an anti-apoptotic aldehyde scavenger.\",\n      \"evidence\": \"Stable transfection of ALDH3A1 in V79 and RAW 264.7 cells with viability, glutathione, adduct, and apoptosis assays\",\n      \"pmids\": [\"11306050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous loss-of-function not yet tested at this point\", \"Relative contribution to total cellular aldehyde metabolism not quantified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Biochemical characterization of recombinant ALDH3A1 defined its substrate specificity as strongly favoring medium-chain (≥C6) aldehydes including 4-HNE, while excluding short-chain aldehydes and sugar phosphates, resolving the enzyme's metabolic niche.\",\n      \"evidence\": \"Recombinant protein expressed in Sf9 cells, purified and assayed with comprehensive substrate panel\",\n      \"pmids\": [\"12943535\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo substrate confirmation not performed at this stage\", \"Cofactor preference (NAD⁺ vs. NADP⁺) kinetics not fully dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"UV radiation was shown to inactivate ALDH3A1 through post-translational aggregation rather than direct active-site damage, establishing that ALDH3A1 acts as a sacrificial UV absorber in the cornea.\",\n      \"evidence\": \"In vivo UV exposure of C57BL/6J mouse corneas; in vitro UV irradiation of recombinant ALDH3A1 and stably transfected HCE cells with spectroscopic and aggregation analyses\",\n      \"pmids\": [\"12604188\", \"21203538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Turnover and replacement kinetics of UV-damaged ALDH3A1 in vivo not determined\", \"Whether aggregated ALDH3A1 retains chaperone function unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"ALDH3A1 was shown to protect other enzymes from aldehyde-mediated inactivation and to absorb UVB shielding partner proteins; additionally, a structural transition near physiological temperature suggested intrinsic chaperone-like activity, expanding the functional repertoire beyond catalysis.\",\n      \"evidence\": \"In vitro co-incubation of recombinant ALDH3A1 with G6PDH under aldehyde/UV stress, spectroscopic structural analysis\",\n      \"pmids\": [\"17158879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chaperone activity not yet demonstrated with dedicated chaperone assay clients\", \"In vivo relevance of chaperone function not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic loss-of-function in vivo proved ALDH3A1's physiological importance: Aldh3a1-knockout mice developed cataracts with elevated protein oxidation and lipid aldehyde adducts, demonstrating that ALDH3A1 is essential for lens and corneal transparency through both enzymatic detoxification and UV absorption.\",\n      \"evidence\": \"Single and double (Aldh1a1/Aldh3a1) knockout mice with slit-lamp exam, histology, proteasome activity, protein carbonylation, and 4-HNE/MDA adduct measurements\",\n      \"pmids\": [\"17567582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of enzymatic vs. crystallin/UV-filter functions not separated in vivo\", \"Corneal vs. lens-specific effects not fully delineated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystal structures of ALDH3A1 with selective inhibitors CB7 and CB29 mapped the aldehyde-binding pocket and enabled isoenzyme-selective pharmacology, demonstrating that ALDH3A1 inhibition sensitizes cancer cells to alkylating chemotherapy.\",\n      \"evidence\": \"X-ray crystallography, kinetic and mutagenesis studies, isoenzyme selectivity panels, mafosfamide sensitization assays in A549 and SF767 cells\",\n      \"pmids\": [\"24387105\", \"24677340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo chemosensitization not tested with these inhibitors\", \"Structural basis for cofactor selectivity not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"FBXL12 was identified as the E3 ubiquitin ligase that targets ALDH3A1 for proteasomal degradation, and accumulation of ALDH3A1 in FBXL12-knockout placenta impaired trophoblast differentiation, revealing a developmental role for ALDH3A1 protein turnover.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitylation assays, FBXL12-KO mice, trophoblast stem cell differentiation assays with forced ALDH3A1 expression\",\n      \"pmids\": [\"26124079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FBXL12 regulation of ALDH3A1 operates in cornea or lung tissues unknown\", \"Degron motif on ALDH3A1 not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Pharmacological expansion of ALDH3A1's substrate range was demonstrated: the small molecule Alda-89 enabled ALDH3A1 to metabolize acetaldehyde, reducing blood ethanol/acetaldehyde levels in mice, showing that ALDH3A1 can be therapeutically redirected.\",\n      \"evidence\": \"In vitro enzymatic assay and in vivo mouse models (wild-type and ALDH2*1/*2 knock-in) with blood alcohol/aldehyde measurement\",\n      \"pmids\": [\"25713355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which Alda-89 alters substrate acceptance not resolved\", \"Long-term safety of ALDH3A1 substrate redirection not assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Dissection of enzymatic vs. non-enzymatic functions revealed that wild-type but not catalytically inactive ALDH3A1 promotes p53 nuclear sequestration and suppresses corneal epithelial proliferation, while DKO mice show corneal hyperproliferation with p53 loss.\",\n      \"evidence\": \"Tet-inducible wild-type and catalytic-mutant ALDH3A1 cell lines, proliferation assays, p53 nuclear fractionation, Aldh1a1/3a1 DKO mouse corneal analysis\",\n      \"pmids\": [\"26751691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking ALDH3A1 catalytic activity to p53 nuclear retention unknown\", \"Whether a metabolic product mediates the p53 effect not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Formal demonstration of ALDH3A1's chaperone activity was achieved: recombinant protein protected SmaI and citrate synthase from thermal inactivation in vitro, and overexpression in E. coli and corneal cells conferred stress resistance independent of catalysis.\",\n      \"evidence\": \"In vitro chaperone assays with multiple client proteins, E. coli thermal shock, HCE-2 cell oxidative stress assays\",\n      \"pmids\": [\"28526614\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether chaperone and catalytic functions are structurally separable not resolved\", \"Client specificity in vivo not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"ALDH3A1 was placed at the nexus of cancer chemoresistance through multiple signaling axes: downstream of PER2 circadian regulation and Wnt/β-catenin signaling, and as a mediator of resistance to glutathione depletion-induced cell death via 4-HNE detoxification in HNSCC.\",\n      \"evidence\": \"shRNA knockdown in Per2-mutant fibroblasts and GBM cells with chemosensitivity/ROS assays; pharmacological Wnt inhibition; shRNA in sulfasalazine-resistant HNSCC with 4-HNE measurement and in vivo tumor assays\",\n      \"pmids\": [\"30429219\", \"29854309\", \"30333913\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional regulation by PER2 or β-catenin on ALDH3A1 promoter not confirmed by ChIP\", \"Whether these pathways converge on shared regulatory elements unknown\", \"Single-lab findings for each axis\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Chemoproteomics identified the catalytic cysteine as the site of covalent inhibitor EN40 binding, and EN40 impaired lung cancer growth in vivo, validating ALDH3A1 as a druggable cancer target.\",\n      \"evidence\": \"Activity-based protein profiling in NSCLC cells, covalent ligand screen, in vitro and in vivo xenograft validation\",\n      \"pmids\": [\"30004670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity profile of EN40 across full ALDH superfamily not complete\", \"Mechanism of anti-proliferative effect beyond ALDH3A1 inhibition not excluded\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR-knockout zebrafish confirmed 4-HNE as the primary in vivo substrate of Aldh3a1 and revealed an unexpected role in glucose homeostasis, linking lipid aldehyde detoxification to pancreatic function.\",\n      \"evidence\": \"aldh3a1-null zebrafish with transgenic reporters, metabolomics, reactive carbonyl species measurement, transcriptomics\",\n      \"pmids\": [\"32980661\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking 4-HNE accumulation to pancreatic disruption not molecularly defined\", \"Whether mammalian ALDH3A1 has a similar metabolic role unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"ALDH3A1 was identified as a mechanosensitive gene in corneal keratocytes: mechanical strain upregulates ALDH3A1, which inhibits NF-κB nuclear translocation to suppress proliferation and migration, linking biomechanical cues to ALDH3A1's anti-proliferative function.\",\n      \"evidence\": \"Flexcell tension system, RNAi, NF-κB immunofluorescence, BrdU proliferation, scratch wound, mouse injury models, scRNA-seq of keratoconus samples\",\n      \"pmids\": [\"39652089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanotransduction pathway from strain to ALDH3A1 transcription not identified\", \"Whether the NF-κB inhibition depends on catalytic activity or protein–protein interaction unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"TP63 super-enhancer binding was shown to drive high ALDH3A1 expression in squamous cell carcinomas, and ALDH3A1 enzymatic activity was demonstrated to protect specifically against ferroptosis by mitigating lipid peroxidation-derived aldehydes.\",\n      \"evidence\": \"ChIP-seq, EN40 covalent inhibitor, viability assays, organoid models, xenograft, lipid peroxidation measurement\",\n      \"pmids\": [\"39863749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ALDH3A1 is the primary or sole effector of TP63-driven ferroptosis resistance not excluded\", \"Specific aldehyde substrates mediating ferroptosis protection not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Dietary isothiocyanates were shown to irreversibly inhibit ALDH3A1 by forming a covalent adduct at the catalytic Cys243, disrupting aldehyde metabolism in saliva—establishing a physiologically relevant environmental inhibitor of ALDH3A1.\",\n      \"evidence\": \"X-ray crystallography, mass spectrometry, enzymatic assays, ex vivo saliva assays, GC-MS aroma analysis\",\n      \"pmids\": [\"41672019\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Systemic consequences of dietary ALDH3A1 inhibition beyond salivary function not explored\", \"Whether chronic isothiocyanate exposure affects corneal or lung ALDH3A1 unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the molecular mechanism by which ALDH3A1 catalytic activity promotes p53 nuclear retention, the structural basis for its chaperone function and whether it can be genetically separated from catalysis, the identity of specific aldehyde products that mediate its anti-ferroptotic and anti-proliferative effects, and whether its metabolic roles in glucose homeostasis observed in zebrafish extend to mammals.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism of p53 nuclear sequestration by ALDH3A1 unknown\", \"Chaperone vs. catalytic domains not structurally separated\", \"Mammalian relevance of glucose homeostasis phenotype unconfirmed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 3, 6, 9, 20, 26]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [4, 11]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [1, 2, 3, 5, 6, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 2, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 9, 20, 28]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 2, 3, 5, 6, 11, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 2, 3, 22]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 29]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FBXL12\",\n      \"TP63\",\n      \"NRF2\",\n      \"AHR\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}